Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Free Cash Flow Generation Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Free Cash Flow Generation Index of 0.87x as of March 2026. Free cash flow of TL156.37 Million represents 1% of operating cash flow (TL180.45 Million). Explore how much does Meditera Tibbi Malzeme Sanayi ve Ticaret reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. For the full cash flow conversion analysis, see Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) cash conversion ratio.
Annual Free Cash Flow Generation for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year Free Cash Flow Generation Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. Check Meditera Tibbi Malzeme Sanayi ve Ticaret cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TRY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | TL243.68 Million | TL435.35 Million | TL191.67 Million | ▼ -15.5% |
| 2024 | 0.66x | TL517.17 Million | TL780.69 Million | TL263.52 Million | ▲ +5.8% |
| 2023 | 0.63x | TL501.32 Million | TL801.02 Million | TL299.70 Million | ▲ +106.8% |
| 2022 | -9.19x | TL-46.87 Million | TL5.10 Million | TL51.35 Million | ▼ -1328.3% |
| 2021 | 0.75x | TL27.42 Million | TL36.64 Million | TL8.92 Million | ▲ +73.2% |
| 2020 | 0.43x | TL31.65 Million | TL73.26 Million | TL20.85 Million | ▼ -56.8% |
| 2019 | 1.00x | TL20.01 Million | TL20.01 Million | TL0.00 | ▲ +0.0% |
| 2018 | 1.00x | TL73.26 Million | TL73.26 Million | TL0.00 | — |